$6.44
-0.39-5.71%
At close: -
$6.44
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Nu Skin Enterprises Stock Guidance | NYSE:NUS | Benzinga
Nu Skin Enterprises issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/13/2025 | NUS | Nu Skin Enterprises | Q1 | 2025 | $0.10 | $0.20 | $0.16 | $345.00M | $365.00M | $404.60M | Get Alert |
| 02/13/2025 | NUS | Nu Skin Enterprises | FY | 2025 | $0.90 | $1.30 | $0.76 | $1.48B | $1.62B | $1.70B | Get Alert |
| 01/13/2025 | NUS | Nu Skin Enterprises | Q4 | 2024 | $0.29 | $0.29 | $0.25 | $445.00M | $445.00M | $433.83M | Get Alert |
| 11/07/2024 | NUS | Nu Skin Enterprises | FY | 2024 | $0.65 | $0.75 | $0.77 | $1.70B | $1.73B | $1.75B | Get Alert |
| 11/07/2024 | NUS | Nu Skin Enterprises | Q4 | 2024 | $0.19 | $0.29 | $0.20 | $410.00M | $445.00M | $440.95M | Get Alert |
| 08/08/2024 | NUS | Nu Skin Enterprises | FY | 2024 | $0.75 | $0.95 | $1.10 | $1.73B | $1.81B | $1.77B | Get Alert |
| 08/08/2024 | NUS | Nu Skin Enterprises | Q3 | 2024 | $0.15 | $0.25 | $0.42 | $430.00M | $465.00M | $459.86M | Get Alert |
| 05/08/2024 | NUS | Nu Skin Enterprises | Q2 | 2024 | $0.10 | $0.20 | $0.34 | $420.00M | $455.00M | $453.02M | Get Alert |
| 05/08/2024 | NUS | Nu Skin Enterprises | FY | 2024 | $0.95 | $1.35 | $1.14 | $1.73B | $1.87B | $1.81B | Get Alert |
| 02/14/2024 | NUS | Nu Skin Enterprises | FY | 2024 | $0.95 | $1.35 | $2.05 | $1.73B | $1.87B | $2.01B | Get Alert |
| 02/14/2024 | NUS | Nu Skin Enterprises | Q1 | 2024 | $0.00 | $0.10 | $0.34 | $400.00M | $435.00M | $479.67M | Get Alert |
| 01/08/2024 | NUS | Nu Skin Enterprises | Q4 | 2023 | $0.15 | $0.30 | $0.28 | $440.00M | $480.00M | $472.40M | Get Alert |
| 11/01/2023 | NUS | Nu Skin Enterprises | FY | 2023 | $1.62 | $1.77 | $2.43 | $1.92B | $1.96B | $2.05B | Get Alert |
| 11/01/2023 | NUS | Nu Skin Enterprises | Q4 | 2023 | $0.15 | $0.30 | $0.90 | $440.00M | $480.00M | $547.02M | Get Alert |
| 08/01/2023 | NUS | Nu Skin Enterprises | Q3 | 2023 | $0.54 | $0.69 | $0.69 | $500.00M | $540.00M | $528.66M | Get Alert |
| 08/01/2023 | NUS | Nu Skin Enterprises | FY | 2023 | $2.30 | $2.60 | $2.61 | $2.00B | $2.08B | $2.08B | Get Alert |
| 05/03/2023 | NUS | Nu Skin Enterprises | FY | 2023 | $2.41 | $2.81 | $2.55 | $2.03B | $2.18B | $2.09B | Get Alert |
| 05/03/2023 | NUS | Nu Skin Enterprises | Q2 | 2023 | $0.45 | $0.55 | $0.61 | $485.00M | $525.00M | $526.75M | Get Alert |
| 03/30/2023 | NUS | Nu Skin Enterprises | FY | 2023 | $2.35 | $2.75 | $2.55 | $2.03B | $2.18B | $2.09B | Get Alert |
| 03/30/2023 | NUS | Nu Skin Enterprises | Q1 | 2023 | $0.25 | $0.35 | $0.33 | $450.00M | $490.00M | $476.03M | Get Alert |
| 02/15/2023 | NUS | Nu Skin Enterprises | FY | 2023 | $2.35 | $2.75 | $2.92 | $2.03B | $2.18B | $2.24B | Get Alert |
| 02/15/2023 | NUS | Nu Skin Enterprises | Q1 | 2023 | $0.25 | $0.35 | $0.70 | $450.00M | $490.00M | $544.24M | Get Alert |
| 11/02/2022 | NUS | Nu Skin Enterprises | FY | 2022 | $2.40 | $2.60 | $3.34 | $2.20B | $2.25B | $2.36B | Get Alert |
| 11/02/2022 | NUS | Nu Skin Enterprises | Q4 | 2022 | $0.40 | $0.60 | $1.09 | $500.00M | $550.00M | $645.47M | Get Alert |
| 08/04/2022 | NUS | Nu Skin Enterprises | FY | 2022 | $3.30 | $3.60 | $3.54 | $2.33B | $2.41B | $2.48B | Get Alert |
| 08/04/2022 | NUS | Nu Skin Enterprises | Q3 | 2022 | $0.70 | $0.85 | $0.89 | $550.00M | $590.00M | $630.91M | Get Alert |
| 07/07/2022 | NUS | Nu Skin Enterprises | Q2 | 2022 | — | — | — | $557.00M | $562.00M | $604.73M | Get Alert |
| 05/04/2022 | NUS | Nu Skin Enterprises | Q2 | 2022 | $0.75 | $0.85 | $1.19 | $590.00M | $620.00M | $695.59M | Get Alert |
| 05/04/2022 | NUS | Nu Skin Enterprises | FY | 2022 | $3.60 | $3.90 | $4.21 | $2.51B | $2.62B | $2.70B | Get Alert |
| 02/16/2022 | NUS | Nu Skin Enterprises | Q1 | 2022 | $0.65 | $0.75 | $0.82 | $560.00M | $590.00M | $618.65M | Get Alert |
| 02/16/2022 | NUS | Nu Skin Enterprises | FY | 2022 | $4.05 | $4.45 | $4.06 | $2.66B | $2.77B | $2.69B | Get Alert |
| 11/03/2021 | NUS | Nu Skin Enterprises | Q4 | 2021 | $0.90 | $1.00 | $0.96 | $645.00M | $675.00M | $631.90M | Get Alert |
| 11/03/2021 | NUS | Nu Skin Enterprises | FY | 2021 | $3.93 | $4.03 | $3.88 | $2.67B | $2.70B | $2.66B | Get Alert |
| 10/04/2021 | NUS | Nu Skin Enterprises | Q3 | 2021 | — | — | — | $637.00M | $642.00M | $710.11M | Get Alert |
| 08/04/2021 | NUS | Nu Skin Enterprises | Q3 | 2021 | $1.10 | $1.20 | $1.11 | $700.00M | $730.00M | $730.56M | Get Alert |
| 08/04/2021 | NUS | Nu Skin Enterprises | FY | 2021 | $4.30 | $4.50 | $4.26 | $2.81B | $2.87B | $2.86B | Get Alert |
| 05/05/2021 | NUS | Nu Skin Enterprises | Q2 | 2021 | $0.97 | $1.07 | $1.03 | $680.00M | $705.00M | $691.15M | Get Alert |
| 05/05/2021 | NUS | Nu Skin Enterprises | FY | 2021 | $4.05 | $4.30 | $3.99 | $2.80B | $2.87B | $2.78B | Get Alert |
| 02/10/2021 | NUS | Nu Skin Enterprises | Q1 | 2021 | $0.65 | $0.75 | $0.75 | $610.00M | $640.00M | $647.09M | Get Alert |
| 02/10/2021 | NUS | Nu Skin Enterprises | FY | 2021 | $3.80 | $4.10 | $3.82 | $2.71B | $2.81B | $2.89B | Get Alert |
| 11/04/2020 | NUS | Nu Skin Enterprises | FY | 2020 | $3.35 | $3.45 | $3.17 | $2.55B | $2.58B | $2.53B | Get Alert |
| 11/04/2020 | NUS | Nu Skin Enterprises | Q4 | 2020 | $1.10 | $1.20 | $1.05 | $720.00M | $750.00M | $706.06M | Get Alert |
| 10/01/2020 | NUS | Nu Skin Enterprises | Q3 | 2020 | — | — | — | $700.00M | $703.00M | $624.64M | Get Alert |
| 08/05/2020 | NUS | Nu Skin Enterprises | Q3 | 2020 | $0.78 | $0.88 | $0.66 | $605.00M | $635.00M | $564.73M | Get Alert |
| 08/05/2020 | NUS | Nu Skin Enterprises | FY | 2020 | $2.85 | $3.10 | $2.40 | $2.37B | $2.45B | $2.28B | Get Alert |
FAQ
What is the most recent guidance for Nu Skin Enterprises (NUS)?
The most recent guidance for Nu Skin Enterprises (NUS) was reported on February 13, 2025 for Q1 2025. The company provided earnings per share guidance in the range of $0.10 to $0.20, compared to the estimated EPS of $0.16. Additionally, Nu Skin Enterprises forecasted revenue between $0.35B and $0.37B for the quarter.
Browse guidance and forecast on all stocks.